Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mutual Influence of 15-Valent Pneumococcal Conjugate Vaccine and DTaP in Infants
NCT06817187Phase 3Completed
- Sponsor
- Zhifei Green Bamboo
- Start
- Sep 2021
- Primary completion
- Mar 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of 15-valent pneumococcal conjugate vaccine in pneumococcal infection (3 arms), sponsored by Zhifei Green Bamboo. Primary endpoint: Antibody positive conversion rate. Started Sep 2021; status: completed.
02
Drugs
15-valent pneumococcal conjugate vaccine
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT06817187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06817187.